Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription 21.10.2019 1 AIDS 1 Antimicrob Agents Chemother 2 Clin Infect Dis 1 Eur J Clin Microbiol Infect Dis 4 Eur Respir J 11 Int J Tuberc Lung Dis 1 J Clin Microbiol 1 J Immunol 1 J Infect Dis 1 Lancet Glob Health 2 Lancet Respir Med 2 PLoS One 1 Respir Med

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. KROEZE S, Ondoa P, Kityo CM, Siwale M, et al
   Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
   AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001801.
   PubMed     Text format     Abstract available
   
   

   
   Antimicrob Agents Chemother

2. DONNELLAN S, Aljayyoussi G, Moyo E, Ardrey A, et al
   Intracellular pharmacodynamic modelling (PDi) is predictive of the clinical activity of fluoroquinolones against Tuberculosis.
   Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.00989.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

3. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
   Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
   Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
4. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
   High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
   Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

5. SAAD J, Loukil A, Drancourt M
   Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2019 Oct 14. pii: 10.1007/s10096-019-03700.
   PubMed     Text format    
   
   

   
   Eur Respir J

6. CAMINERO JA, Garcia-Basteiro AL, Rendon A, Piubello A, et al
   The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines.
   Eur Respir J. 2019;54.
   PubMed     Text format    
   
   
7. DIEL R, Schluger NW
   Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary?
   Eur Respir J. 2019;54.
   PubMed     Text format    
   
   
8. OLAYANJU O, Esmail A, Limberis J, Dheda K, et al
   A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug resistant tuberculosis.
   Eur Respir J. 2019 Oct 16. pii: 13993003.01181-2019.
   PubMed     Text format     Abstract available
   
   
9. BORISOV S, Danila E, Maryandyshev A, Dalcolmo M, et al
   Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
   Eur Respir J. 2019 Oct 10. pii: 13993003.01522-2019.
   PubMed     Text format     Abstract available
   
   

   
   Int J Tuberc Lung Dis

10. ZHANG HC, Ruan QL, Wu J, Zhang S, et al
    Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China.
    Int J Tuberc Lung Dis. 2019;23:989-995.
    PubMed     Text format     Abstract available
    
    
11. HELD K, McAnaw S, Chiang CY, Trebucq A, et al
    Progress in global rollout of new multidrug-resistant tuberculosis treatments.
    Int J Tuberc Lung Dis. 2019;23:996-999.
    PubMed     Text format     Abstract available
    
    
12. OTA M, Uchimura K
    Trends of tuberculosis rates before and after the declaration as a public health emergency in Japan, 1992-2006.
    Int J Tuberc Lung Dis. 2019;23:1000-1004.
    PubMed     Text format     Abstract available
    
    
13. DI BELLA S, Siroka A, Antonello RM, Zignol M, et al
    Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Int J Tuberc Lung Dis. 2019;23:1024-1028.
    PubMed     Text format     Abstract available
    
    
14. FARLEY JE, McKenzie-White J, Bollinger R, Hong H, et al
    Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:980-988.
    PubMed     Text format     Abstract available
    
    
15. SMITTIPAT N, Miyahara R, Juthayothin T, Billamas P, et al
    Indo-Oceanic Mycobacterium tuberculosis strains from Thailand associated with higher mortality.
    Int J Tuberc Lung Dis. 2019;23:972-979.
    PubMed     Text format     Abstract available
    
    
16. BUZIASHVILI M, Mirtskhulava V, Kipiani M, Blumberg HM, et al
    Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.
    Int J Tuberc Lung Dis. 2019;23:1005-1011.
    PubMed     Text format     Abstract available
    
    
17. PEREA-JACOBO R, Muniz-Salazar R, Laniado-Laborin R, Cabello-Pasini A, et al
    Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.
    Int J Tuberc Lung Dis. 2019;23:1012-1016.
    PubMed     Text format     Abstract available
    
    
18. HUGHES J, Reuter A, Chabalala B, Isaakidis P, et al
    Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.
    Int J Tuberc Lung Dis. 2019;23:1017-1023.
    PubMed     Text format     Abstract available
    
    
19. GALEGO MA, Santos JV, Viana J, Freitas A, et al
    To be or not to be hospitalised with tuberculosis in Portugal.
    Int J Tuberc Lung Dis. 2019;23:1029-1034.
    PubMed     Text format     Abstract available
    
    
20. VANINO E, Tadolini M, Attard L, Cascavilla A, et al
    A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
    Int J Tuberc Lung Dis. 2019;23:1042.
    PubMed     Text format    
    
    

    
    J Clin Microbiol

21. LISBOA VDC, Ribeiro-Alves M, Correa RDS, Lopes IR, et al
    The predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis Among Other Exudative Etiologies.
    J Clin Microbiol. 2019 Oct 16. pii: JCM.00927-19. doi: 10.1128/JCM.00927.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

22. PADHI A, Pattnaik K, Biswas M, Jagadeb M, et al
    Mycobacterium tuberculosis LprE Suppresses TLR2-Dependent Cathelicidin and Autophagy Expression to Enhance Bacterial Survival in Macrophages.
    J Immunol. 2019 Oct 16. pii: jimmunol.1801301. doi: 10.4049/jimmunol.1801301.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

23. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
    Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
    J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Glob Health

24. REID M, Von Zinkernagel D, Beyeler N, Goosby E, et al
    Global Fund replenishment brings us one step closer to ending tuberculosis.
    Lancet Glob Health. 2019 Oct 9. pii: S2214-109X(19)30424.
    PubMed     Text format    
    
    

    
    Lancet Respir Med

25. MUSHTAQ A
    Breakthrough in the treatment of drug-resistant tuberculosis.
    Lancet Respir Med. 2019 Oct 10. pii: S2213-2600(19)30376.
    PubMed     Text format    
    
    
26. SHARMA DC
    India launches tuberculosis prevalence survey.
    Lancet Respir Med. 2019 Oct 10. pii: S2213-2600(19)30377.
    PubMed     Text format    
    
    

    
    PLoS One

27. BOUTON TC, de Vos M, Ragan EJ, White LF, et al
    Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    PLoS One. 2019;14:e0223308.
    PubMed     Text format     Abstract available
    
    
28. TAGHIPOUR A, Mosadegh M, Kheirollahzadeh F, Olfatifar M, et al
    Are intestinal helminths playing a positive role in tuberculosis risk? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223722.
    PubMed     Text format     Abstract available
    
    

    
    Respir Med

29. HUANG CT, Lee MR, Ruan SY, Tsai YJ, et al
    Prognostic value of the mitogen response in the interferon-gamma release assay in patients with culture-confirmed tuberculosis.
    Respir Med. 2019;158:49-54.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: